2-amino-5-chloro-α-(2'-chlorophenyl)benzyl alcohol | 74067-45-1

• 分子结构分类: 有机化合物 - 苯类化合物 - 苯和取代衍生物
• 英文名称: 2-amino-5-chloro-α-(2'-chlorophenyl)benzyl alcohol
• 英文别名: rac-(2-amino-5-chloro-phenyl)-(2-chloro-phenyl)-methanol；2-amino-5,2'-dichlorobenzhydrol；2-amino-2',5-dichlorobenzhydrol；(2-amino-5-chlorophenyl)(2-chlorophenyl)methanol；(2‐amino‐5‐chlorophenyl)(2‐chlorophenyl)methanol；4-chloro-2-[α-hydroxy-(2-chlorophenyl)methyl]aniline；(2-amino-5-chlorophenyl)-(2-chlorophenyl)methanol
• CAS: 74067-45-1
• 化学式: C₁₃H₁₁Cl₂NO
• 分子量: 268.142
• InChiKey: WRZHNTKVHYRWHJ-UHFFFAOYSA-N

物化性质

• 熔点：
  98-99 °C(Solv: ethanol (64-17-5))
• 沸点：
  436.5±40.0 °C(Predicted)
• 密度：
  1.387±0.06 g/cm3(Predicted)

计算性质

• 辛醇/水分配系数(LogP)：
  3.9
• 重原子数：
  17
• 可旋转键数：
  2
• 环数：
  2.0
• sp3杂化的碳原子比例：
  0.08
• 拓扑面积：
  46.2
• 氢给体数：
  2
• 氢受体数：
  2

反应信息

• 作为反应物：
  描述：

  2-amino-5-chloro-α-(2'-chlorophenyl)benzyl alcohol 在 4-二甲氨基吡啶 、 sodium hydroxide 、 盐酸-N-乙基-Nˊ-(3-二甲氨基丙基)碳二亚胺 、 N,N-二异丙基乙胺 、 三氟乙酸 作用下， 以 四氢呋喃 、 甲醇 、 水 为溶剂， 反应 117.0h， 生成 7-氯-5-(2-氯苯基)-1,5-二氢-4,1-苯并硫氮杂卓-2(3H)-酮
  参考文献：
  名称：

  Efficient Syntheses of Benzothiazepines as Antagonists for the Mitochondrial Sodium−Calcium Exchanger:  Potential Therapeutics for Type II Diabetes

  摘要：

  Type II diabetes mellitus is a chronic metabolic disorder that can lead to serious cardiovascular, renal, neurologic, and retinal complications. While several drugs are currently prescribed to treat type II diabetes, their efficacy is limited by mechanism-related side effects (weight gain, hypoglycemia, gastrointestinal distress), inadequate efficacy for use as monotherapy, and the development of tolerance to the agents. Consequently, combination therapies are frequently employed to effectively regulate blood glucose levels. We have focused on the mitochondrial sodium-calcium exchanger (mNCE) as a novel target for diabetes drug discovery. We have proposed that inhibition of the mNCE can be used to regulate calcium flux across the mitochondrial membrane, thereby enhancing mitochondrial oxidative metabolism, which in turn enhances glucose-stimulated insulin secretion (GSIS) in the pancreatic beta-cell. In this paper, we report the facile synthesis of benzothiazepines and derivatives by S-alkylation using 2-aminobenzhydrols. The syntheses of other bicyclic analogues based on benzothiazepine, benzothiazecine, benzodiazecine, and benzodiazepine templates are also described. These compounds have been evaluated for their inhibition of mNCE activity, and the results from the structure-activity relationship (SAR) studies are discussed.

  DOI：

  10.1021/jo020446t
• 作为产物：
  描述：

  邻氯苯乙腈 在 氢氧化钾 、 lithium aluminium tetrahydride 、 水 、 potassium carbonate 作用下， 以 甲醇 、 乙醚 、 苯 为溶剂， 反应 2.5h， 生成 2-amino-5-chloro-α-(2'-chlorophenyl)benzyl alcohol
  参考文献：
  名称：

  Psychotropic derivatives of 5-phenyl-7-chloro-1,3-dihydro-1,4-benzodiazepin-2-one and contribution to the synthesis of its 5-(2-chlorophenyl) analogue

  摘要：

  将7-氯-5-苯基-1,3-二氢-1,4-苯二氮杂环己-2-酮（I）与2,5-二甲氧基苯乙酰溴和3-(4-苯基哌嗪基)丙基氯烷基化，得到了诺多西泮（III）和（IV）的N-取代衍生物；化合物（IV）表现出潜在催眠药物的特性。4-氯硝基苯与(2-氯苯基)乙腈在碱性氢氧化物甲醇溶液中反应，得到混合物，从中分离出以下化合物：5-氯-3-(2-氯苯基)-2,1-苯并异噁唑（VII）、O-甲氧基肟（X）、5-氯-2,3-双(2-氯苯基)吲哚（XI）、2-氯-4'-硝基苯基酮（XVII）和2-氯-9-氰基喹啉-N-氧化物（XX）。4-氯硝基苯与(2-氟苯基)乙腈进行类似反应，得到化合物XX作为主要产物；少量得到4-硝基苯甲醚、2-氟-4'-硝基苯基酮（XVIII）和2-氯喹啉-9-碳腈（XXIV）。化合物VII还原为氨基苯基酮衍生物V，经过邻苯二甲酰亚乙酸酰衍生物VI转化为氯代甲基二氮杂西泮II。

  DOI：

  10.1135/cccc19803593

文献信息

• Synthesis of the antitumoural agent batracylin and related isoindolo[1,2-b]quinazolin-12(10H)-ones
  作者：Carlos M. Martínez-Viturro、Domingo Domínguez

  DOI：10.1016/j.tetlet.2006.11.168

  日期：2007.2

  The synthesis of batracylin and related isoindolo[1,2-b]quinazolin-12-ones from easily accessible o-acylanilines is reported. The preparation of these tetracyclic compounds through a Mitsunobu reaction followed by spontaneous cyclodehydration shows the ability of this methodology to afford good yields of a wide variety of diversely 7, 8, 9, 10-substituted isoindoloquinazolinones in two steps.

  据报道，从容易获得的邻苯丙氨酸类化合物中合成巴统西林和相关的异吲哚并[1,2 - b ]喹唑啉-12-酮。通过Mitsunobu反应然后自发环脱水制备这些四环化合物，表明该方法能够分两步提供多种多样的7、8、9、10取代异吲哚并喹唑啉酮的良好收率。
• SULPHONAMIDE DERIVATIVES, THEIR PREPARATION AND THEIR THERAPEUTIC APPLICATION
  申请人：COURTEMANCHE Gilles

  公开号：US20070185136A1

  公开（公告）日：2007-08-09

  Disclosed are compounds having the general formula (I) as defined herein, the preparation thereof, and the use thereof for the prophylaxis or treatment of any disease involving a dysfunction associated with the orexin 2 receptor such as obesity, appetite or taste disorders including cachexia, anorexia and bulimia, diabetes, metabolic syndromes, vomiting and nausea, depression and anxiety, addictions, mood and behaviour disorders, schizophrenia, sleep disorders, restless legs syndrome, memory learning disorders, sexual and psychosexual dysfunctions, pain, visceral or neuropathic pain, hyperalgesia, allodynia, digestive disorders, irritable bowel syndrome, neuronal degenerescence, ischaemic or haemorrhagic attacks, Cushing's disease, Guillain-Barré syndrome, myotonic dystrophy, urinary incontinence, hyperthyroidism, pituitary function disorders, hypertension or hypotension.

  揭示了具有以下通用公式（I）的化合物，其制备方法以及用于预防或治疗涉及与促进素2受体相关的任何疾病的用途，如肥胖、食欲或味觉障碍，包括虚弱、厌食症和暴食症、糖尿病、代谢综合征、呕吐和恶心、抑郁和焦虑、成瘾、情绪和行为障碍、精神分裂症、睡眠障碍、不宁腿综合征、记忆学习障碍、性和心理性功能障碍、疼痛、内脏或神经痛、疼痛过敏、消化障碍、肠易激综合征、神经元退行性疾病、缺血性或出血性发作、库欣氏病、吉兰-巴雷综合征、肌强直性萎缩、尿失禁、甲状腺功能亢进、垂体功能障碍、高血压或低血压。
• 4,1-benzoxazepin derivatives and their use
  申请人：Takeda Chemical Industries, Ltd.

  公开号：US05726306A1

  公开（公告）日：1998-03-10

  N-containing, condensed heterocyclic compounds and salts thereof are disclosed which are useful for inhibiting squalene synthetase and fungal growth, and which are useful for treating or preventing hyperlipidemia. Also disclosed is a method for producing these compounds.

  本发明揭示了一种含氮、紧凑的杂环化合物及其盐，用于抑制角鲨烯合酶和真菌生长，并用于治疗或预防高脂血症。还公开了一种制备这些化合物的方法。
• Novel 4,1-benzoxazepine derivatives with potent squalene synthase inhibitory activities
  作者：Takashi Miki、Masakuni Kori、Hiroshi Mabuchi、Hiroshi Banno、Ryu-ichi Tozawa、Masahira Nakamura、Shigekazu Itokawa、Yasuo Sugiyama、Hidefumi Yukimasa

  DOI：10.1016/s0968-0896(01)00290-5

  日期：2002.2

  inhibitory activity. Among such compounds, the 5-(2,3-dimethoxyphenyl) derivative 2t exhibited potent inhibition of cholesterol biosynthesis in HepG2 cells. As a result of optical resolution study of 2t, the absolute stereochemistry required for inhibitory activity was determined to be 3R,5S. In vivo study showed that the sodium salt of (3R,5S)-7-chloro-5-(2,3-dimethoxyphenyl)-1-neopentyl-2-oxo-1,2,3,5-tetrahydro-4

  合成了一系列的（3,5-反式）-2-氧代-5-苯基-1,2,3,5-四氢-4,1-苯并x氮平衍生物，并评价了其对角鲨烯合酶的抑制作用和对胆固醇生物合成的抑制作用。通过修饰先导化合物1a和1b的取代基，发现在1位带有异丁基和新戊基，在7位具有氯原子和在氯原子上具有4，1-苯并氮杂氮杂-3-乙酸衍生物。在5-苯环的2'-位上的甲氧基具有强力的角鲨烯合酶抑制活性。在这些化合物中，5-（2,3-二甲氧基苯基）衍生物2t在HepG2细胞中显示出有效的胆固醇生物合成抑制作用。作为2t光学拆分研究的结果，抑制活性所需的绝对立体化学被确定为3R，5S。
• Discovery of a new 2-aminobenzhydrol template for highly potent squalene synthase inhibitors
  作者：Masanori Ichikawa、Aki Yokomizo、Masao Itoh、Kazuyuki Sugita、Hiroyuki Usui、Hironari Shimizu、Makoto Suzuki、Koji Terayama、Akira Kanda

  DOI：10.1016/j.bmc.2011.01.065

  日期：2011.3

  To obtain small and efficient squalene synthase inhibitors, a flexible 2-aminobenzhydrol open form structure was designed and showed potent inhibitory activity comparable to 4,1-benzoxazepin compounds. Further chemical modification led to the discovery of a novel template with a strong squalene synthase inhibitory activity, and its basic structure–activity relationship was revealed. The X-ray crystallographic

  为了获得小的和有效的角鲨烯合酶抑制剂，设计了一种灵活的2-氨基苯并氢开放形式结构，并显示了与4,1-苯并恶唑啉化合物相当的有效抑制活性。进一步的化学修饰导致发现了具有强鲨烯合酶抑制活性的新型模板，并且揭示了其基本的结构-活性关系。与角鲨烯合酶活性位点结合的化合物12的X射线晶体学数据提供了对该替代模板的结合模式的重要见解，该替代模板形成了具有分子内氢键的11元环构象。